Stockscreener 앱 받기
23.13
5.62%
-1.33
전일 마감가:
$24.46
열려 있는:
$23.95
하루 거래량:
94,641
Relative Volume:
0.12
시가총액:
$1.39B
수익:
$688.00K
순이익/손실:
$-170.19M
주가수익비율:
-7.5848
EPS:
-3.0495
순현금흐름:
$-154.68M
1주 성능:
-6.04%
1개월 성능:
+45.28%
6개월 성능:
+52.78%
1년 성능:
-32.06%
1일 변동 폭
$23.01
$24.45
1주일 범위
$23.01
$25.05
52주 변동 폭
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
명칭
Spyre Therapeutics Inc
전화
(617) 651-5940
주소
221 CRESCENT STREET, WALTHAM
SYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
23.09 | 1.90B | 688.00K | -170.19M | -154.68M | -3.0495 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.12 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
828.79 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-26 | 개시 | Deutsche Bank | Buy |
| 2025-04-08 | 개시 | Leerink Partners | Outperform |
| 2025-03-18 | 개시 | Wolfe Research | Outperform |
| 2024-09-04 | 개시 | Wedbush | Outperform |
| 2024-07-16 | 개시 | Evercore ISI | Outperform |
| 2024-05-02 | 개시 | Robert W. Baird | Outperform |
| 2024-03-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | 개시 | BTIG Research | Buy |
| 2023-12-11 | 개시 | Guggenheim | Buy |
| 2023-12-11 | 개시 | Jefferies | Buy |
| 2020-05-04 | 개시 | Piper Sandler | Overweight |
| 2019-03-21 | 개시 | JP Morgan | Overweight |
| 2018-09-04 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | 개시 | Evercore ISI | Outperform |
| 2018-03-14 | 재확인 | Needham | Buy |
모두보기
Spyre Therapeutics Inc 주식(SYRE)의 최신 뉴스
Why Spyre Therapeutics Inc. stock is seen as undervaluedWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Using data tools to time your Spyre Therapeutics Inc. exitJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Why retail investors favor Spyre Therapeutics Inc. stock2025 Valuation Update & Fast Moving Stock Trade Plans - newser.com
Is Spyre Therapeutics Inc. stock a buy for dividend growthJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com
Can Spyre Therapeutics Inc. stock sustain free cash flow growthShare Buyback & AI Powered Market Entry Strategies - newser.com
Will Spyre Therapeutics Inc. (3920) stock sustain uptrend momentumWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com
What dividend safety score for Spyre Therapeutics Inc. stock2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Why Spyre Therapeutics Inc. stock remains on watchlistsPortfolio Risk Report & Real-Time Market Trend Scan - newser.com
Using Ichimoku Cloud for Spyre Therapeutics Inc. technicalsMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com
How to escape a deep drawdown in Spyre Therapeutics Inc.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Is a relief rally coming for Spyre Therapeutics Inc. holdersWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Will Spyre Therapeutics Inc. stock recover faster than peers2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
What insider purchases suggest about Spyre Therapeutics Inc. (3920) stockMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Published on: 2025-11-02 03:35:20 - newser.com
Is Spyre Therapeutics Inc. (3920) stock inflation resilient2025 Analyst Calls & Risk Managed Investment Signals - newser.com
Why Spyre Therapeutics Inc. stock remains undervalued2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
Will Spyre Therapeutics Inc. stock deliver strong dividend growth2025 Geopolitical Influence & Daily Stock Trend Watchlist - newser.com
Earnings visualization tools for Spyre Therapeutics Inc.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
What sentiment indicators say about Spyre Therapeutics Inc. stock2025 Price Momentum & Long-Term Safe Return Strategies - newser.com
Published on: 2025-11-01 04:11:34 - newser.com
Spyre Therapeutics (SYRE) to Release Quarterly Earnings on Thursday - MarketBeat
Will Spyre Therapeutics Inc. stock maintain dividend yieldWeekly Trend Summary & Community Consensus Stock Picks - newser.com
What drives Spyre Therapeutics Inc 3920 stock priceInsider Buying Signals & Free Professional Investment Consultations - earlytimes.in
Will Spyre Therapeutics Inc. stock sustain high P E ratiosJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
Spyre Therapeutics, Inc. $SYRE Shares Sold by Emerald Mutual Fund Advisers Trust - MarketBeat
Best data tools to analyze Spyre Therapeutics Inc. stockJuly 2025 Action & Weekly Breakout Watchlists - newser.com
Is Spyre Therapeutics Inc. (3920) stock at risk of policy regulationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Is Spyre Therapeutics Inc. (3920) stock undervalued after correctionMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Will Spyre Therapeutics Inc. (3920) stock beat international competitionJuly 2025 Setups & Weekly Watchlist for Hot Stocks - newser.com
Backtesting results for Spyre Therapeutics Inc. trading strategiesQuarterly Investment Review & Community Trade Idea Sharing - newser.com
Spyre Therapeutics Inc (SYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
0.74%
자본화:
|
볼륨(24시간):